Robert Alonso
Direktor/Vorstandsmitglied bei MEDESIS PHARMA S.A.
Profil
Robert J.
Alonso is the founder of Ceptaris Therapeutics, Inc. (founded in 2002) and Mitochon Pharmaceuticals, Inc. (founded in 2014) where he held the titles of President & Chief Executive Officer and Chief Executive Officer, respectively.
He is currently a Member-Supervisory Board at Medesis Pharma SA since 2022.
Mr. Alonso's former positions include being a Principal at Merck & Co., Inc., Roche Pharmaceuticals, Inc., and Layton BioScience, Inc. Mr. Alonso received an MBA degree from Babson College.
Aktive Positionen von Robert Alonso
| Unternehmen | Position | Beginn |
|---|---|---|
| MEDESIS PHARMA S.A. | Direktor/Vorstandsmitglied | 27.10.2022 |
Mitochon Pharmaceuticals, Inc.
 Mitochon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mitochon Pharmaceuticals, Inc. operates as a biotech company. It focuses on developing drugs that target the mitochondria for a host of serious diseases. The firm provides products to resolve the over-nutritional phenotype metabolic disorders. The company was founded by Robert Alonso and John G. Geisler in 2014 and is headquartered in Blue Bell, PA. | Vorstandsvorsitzender | 01.01.2014 |
Ehemalige bekannte Positionen von Robert Alonso
| Unternehmen | Position | Ende |
|---|---|---|
Ceptaris Therapeutics, Inc.
 Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Gründer | 10.05.2011 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
| Layton BioScience, Inc. | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Ausbildung von Robert Alonso
| Babson College | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| MEDESIS PHARMA S.A. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |
Ceptaris Therapeutics, Inc.
Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Health Technology |
Mitochon Pharmaceuticals, Inc.
Mitochon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mitochon Pharmaceuticals, Inc. operates as a biotech company. It focuses on developing drugs that target the mitochondria for a host of serious diseases. The firm provides products to resolve the over-nutritional phenotype metabolic disorders. The company was founded by Robert Alonso and John G. Geisler in 2014 and is headquartered in Blue Bell, PA. | Health Technology |
| Layton BioScience, Inc. |
